Interaction Color Code
Clinical Bottom Line
Minimal data to guide interaction: risks likely to outweigh benefits
Drug 1
Drug 1 dose
200 mg BID with ritonavir 100 mg daily
Drug 1 effect
No significant change
Drug 2 dose
Elvitegravir 150 mg daily
Drug 2 effect
No significant change
Clinical Effects
Potentially decreased or increased elvitegravir, cobicistat and / or etravirine effects
Management
Avoid combination and use alternative agents
Import ID
559
